Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Pozycja w akcjach #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Cena akcji
$0.158
Ostatnia synchronizacja: 2026-04-06
Kapitalizacja rynkowa
$302.92K
Zmiana (1 dzień)
16.18%
Zmiana (1 rok)
-97.91%
Kraj
US
Handel Abpro Corporation (ABP)

Kategoria

Historia ceny akcji dla Abpro Corporation (ABP)
Najwyższa cena zamknięcia: $0.15 dnia 2026-04-01

Najniższa cena zamknięcia: $111.21 dnia 2024-11-01
Historia cen akcji firmy Abpro Corporation od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -20.12%
2025 -91.12%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE